RGP ENTERPRISES LLC – Trademark Portfolio

Entity Type: 16

RGP ENTERPRISES LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ATLAS K.T.W.S. The owner is based in New York, NY.

700 LENOX AVENUE #4A

New York, NY 10039

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

O
O
Abandoned 2023
''ATLAS
''ATLAS
Abandoned 2022
Trademark
Serial #97727614
Registered 2022
O
O
Abandoned 2020

Trademark Classifications

RGP ENTERPRISES LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (3 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does RGP ENTERPRISES LLC have?

RGP ENTERPRISES LLC has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned.

What trademark classes does RGP ENTERPRISES LLC file in?

RGP ENTERPRISES LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are RGP ENTERPRISES LLC's most well-known trademarks?

RGP ENTERPRISES LLC's registered trademark portfolio includes well-known marks such as ATLAS K.T.W.S. These are among 2 currently registered trademarks in the portfolio.

What is RGP ENTERPRISES LLC's trademark registration success rate?

RGP ENTERPRISES LLC has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.